Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV and SARS-CoV-2) Laboratory Testing (June 2020)

Why This Topic Matters

The article reflects rapid code updates issued during the pandemic and shows how laboratory testing for SARS-CoV and SARS-CoV-2 was being organized in CPT. It helps readers understand the scope of the guidance before reviewing the full article.

Article Sections

1. June 2020 page 0

   Introductory material on the June 2020 CPT update and the laboratory testing topic area.

2. Microbiology

   CPT laboratory coding content related to microbiology testing and the new coronavirus-related reporting focus.

3. Proprietary Laboratory Analyses

   PLA-related coding content, including the laboratory analysis category and references to CPT listing locations.

4. Proprietary Name and Clinical Laboratory or Manufacturer

   Manufacturer-linked PLA listing information and how the tests are presented in the CPT appendix context.

5. Clinical Example (87426) / Description of Procedure (87426)

   A combined clinical example and procedure description associated with one of the new laboratory testing codes.

6. Clinical Example (0223U) / Description of Procedure (0223U)

   A combined clinical example and procedure description associated with a molecular respiratory panel PLA code.

7. Clinical Example (0224U) / Description of Procedure (0224U)

   A combined clinical example and procedure description associated with a SARS-CoV-2 antibody PLA code.